News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
564,293 Results
Type
Article (47450)
Company Profile (110)
Press Release (516725)
Multimedia
Podcasts (173)
Webinars (23)
Section
Business (146282)
Career Advice (2433)
Deals (28264)
Drug Delivery (168)
Drug Development (68951)
Employer Resources (160)
FDA (16152)
Job Trends (12118)
News (266700)
Policy (29961)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2360)
Academic (1)
Accelerated approval (57)
ADA (43)
Adcomms (42)
Allergies (183)
Alliances (36283)
ALS (217)
Alzheimer's disease (1874)
Antibody-drug conjugate (ADC) (500)
Approvals (16474)
Artificial intelligence (696)
ASCO (304)
Autoimmune disease (342)
Automation (53)
Bankruptcy (315)
Best Places to Work (9202)
BIO (64)
BIOSECURE Act (23)
Biosimilars (235)
Biotechnology (64)
Bladder cancer (204)
Brain cancer (72)
Breast cancer (738)
Cancer (5963)
Cardiovascular disease (513)
Career advice (2074)
Career pathing (49)
CAR-T (323)
CDC (77)
Celiac Disease (2)
Cell therapy (925)
Cervical cancer (51)
Clinical research (60851)
Collaboration (1930)
Commercialization (1)
Company closure (7)
Compensation (1500)
Complete response letters (108)
COVID-19 (2764)
CRISPR (115)
C-suite (1147)
Cystic fibrosis (157)
Data (8109)
Decentralized trials (3)
Denatured (39)
Depression (191)
Dermatology (95)
Diabetes (627)
Diagnostics (5826)
Digital health (49)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (329)
Drug pricing (242)
Drug shortages (34)
Duchenne muscular dystrophy (317)
Earnings (64342)
Editorial (80)
Employer branding (20)
Employer resources (144)
Events (85109)
Executive appointments (1035)
FDA (20139)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (32)
Funding (1621)
Gene editing (246)
Generative AI (63)
Gene therapy (767)
GLP-1 (1194)
Government (4297)
Grass and pollen (8)
Guidances (409)
Healthcare (15144)
Hematology (173)
HIV (91)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (115)
Immunology and inflammation (348)
Immuno-oncology (101)
Indications (207)
Infectious disease (3118)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (131)
Intellectual property (302)
Interviews (459)
IPO (14175)
IRA (58)
Job creations (3180)
Job search strategy (1678)
JPM (69)
Kidney cancer (23)
Labor market (112)
Layoffs (650)
Leadership (52)
Legal (7030)
Liver cancer (102)
Longevity (27)
Lung cancer (781)
Lymphoma (449)
Machine learning (61)
Management (53)
Manufacturing (1061)
Marketing (4)
MASH (216)
Medical affairs (1)
Medical device (11779)
Medtech (11924)
Mergers & acquisitions (15293)
Metabolic disorders (1690)
mRNA (251)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (468)
Neuropsychiatric disorders (125)
Neuroscience (3476)
Neurotech (2)
NextGen: Class of 2026 (5008)
Non-profit (3214)
Now hiring (37)
Obesity (831)
Opinion (317)
Ovarian cancer (222)
Pain (245)
Pancreatic cancer (344)
Parkinson's disease (388)
Partnered (29)
Patents (616)
Patient recruitment (728)
Peanut (64)
People (45203)
Pharmaceutical (34)
Pharmacy benefit managers (36)
Phase 1 (18292)
Phase 2 (26378)
Phase 3 (21514)
Pipeline (9337)
Policy (393)
Postmarket research (2214)
Preclinical (7469)
Press Release (31)
Prostate cancer (335)
Psychedelics (69)
Radiopharmaceuticals (306)
Rare diseases (1236)
Real estate (4321)
Recruiting (66)
Regulatory (24560)
Reports (47)
Research institute (2153)
Resumes & cover letters (406)
Rett syndrome (46)
RNA editing (25)
RSV (85)
Schizophrenia (188)
Series A (283)
Series B (216)
Service/supplier (7)
Sickle cell disease (121)
Special edition (30)
Spinal muscular atrophy (154)
Sponsored (52)
Startups (2831)
State (1)
Stomach cancer (21)
Supply chain (134)
Tariffs (104)
The Weekly (132)
Vaccines (1232)
Venture capital (135)
Weight loss (580)
Women's health (118)
Worklife (25)
Date
Today (91)
Last 7 days (470)
Last 30 days (2159)
Last 365 days (28550)
2026 (15263)
2025 (28427)
2024 (31428)
2023 (35033)
2022 (45110)
2021 (48534)
2020 (45559)
2019 (36239)
2018 (27420)
2017 (27838)
2016 (25832)
2015 (28006)
2014 (21815)
2013 (17835)
2012 (18995)
2011 (19432)
2010 (17561)
Location
Africa (692)
Alabama (73)
Alaska (6)
Arizona (288)
Arkansas (12)
Asia (33046)
Australia (5802)
California (13029)
Canada (3031)
China (1234)
Colorado (512)
Connecticut (583)
Delaware (394)
Europe (81125)
Florida (1986)
Georgia (398)
Hawaii (4)
Idaho (41)
Illinois (1000)
India (82)
Indiana (521)
Iowa (24)
Japan (573)
Kansas (114)
Kentucky (37)
Louisiana (39)
Maine (77)
Maryland (1561)
Massachusetts (9423)
Michigan (309)
Minnesota (679)
Mississippi (5)
Missouri (137)
Montana (13)
Nebraska (24)
Nevada (136)
New Hampshire (64)
New Jersey (3456)
New Mexico (17)
New York (3364)
North Carolina (1637)
North Dakota (9)
Northern California (6689)
Ohio (364)
Oklahoma (18)
Oregon (34)
Pennsylvania (2453)
Puerto Rico (25)
Rhode Island (34)
South America (1050)
South Carolina (84)
South Dakota (2)
Southern California (5134)
Tennessee (199)
Texas (2010)
United States (45291)
Utah (322)
Vermont (1)
Virginia (319)
Washington D.C. (74)
Washington State (1009)
West Virginia (4)
Wisconsin (132)
Wyoming (1)
564,293 Results for "transgene s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics
March 23, 2026
·
5 min read
Press Releases
Ablexis Reports 33 AlivaMab(R) Mouse-Derived Human Antibodies Now in Clinical Development, Further Validating AlivaMab Mouse Transgenic Platform
March 4, 2026
·
2 min read
Business
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the pharma’s pipeline.
June 22, 2026
·
1 min read
·
Gabrielle Masson
Transgene’s Combined General Meeting of May 5, 2023
The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held at 9:00 a.m. at the Company’s headquarters.
May 5, 2023
·
4 min read
Press Releases
Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
October 13, 2025
·
6 min read
Alzheimer’s disease
Merck axes Alzheimer’s study, adding to partner Neuphoria’s mounting woes
The mid-stage disappointment in Alzheimer’s disease delivers another blow to Neuphoria Therapeutics, which in November last year was forced to launch a strategic business review after a Phase 3 trial in social anxiety disorder failed.
July 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
October 20, 2025
·
9 min read
Huntington’s disease
Skyhawk CEO hopes FDA’s new uniQure position will translate to Huntington’s pill
A recent FDA reversal sparked new hope for patients with Huntington’s disease. Flying under the radar, Skyhawk Therapeutics revealed 12-month functional data from a midstage trial of its own candidate showing improvements on a key disease measurement scale.
June 30, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025
July 28, 2025
·
6 min read
Alzheimer’s disease
Biogen ready to catch Alzheimer’s patients transitioning off Lilly’s Kisunla
Key dosing differences between Eli Lilly’s Kisunla and Biogen’s Leqembi are about to come to a head in the Alzheimer’s market as patients end their 18-month course of Lilly’s product.
April 29, 2026
·
3 min read
·
Annalee Armstrong
1 of 56,430
Next
